KPTI icon

Karyopharm Therapeutics

147 hedge funds and large institutions have $364M invested in Karyopharm Therapeutics in 2022 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 62 increasing their positions, 42 reducing their positions, and 20 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
147
Holders Change
-2
Holders Change %
-1.34%
% of All Funds
2.54%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
18
Increased
62
Reduced
42
Closed
20
Calls
$3.53M
Puts
$2.07M
Net Calls
+$1.46M
Net Calls Change
-$1.31M
Name Holding Trade Value Shares
Change
Shares
Change %
Allianz Asset Management
151
Allianz Asset Management
Germany
-$808K -11,948 Closed
HF
152
HRT Financial
New York
-$221K -3,269 Closed
Arrowstreet Capital
153
Arrowstreet Capital
Massachusetts
-$202K -2,984 Closed
DCM
154
Dupont Capital Management
Delaware
-$164K -2,430 Closed
PHK
155
Point72 Hong Kong
Hong Kong
-$131K -1,941 Closed
VF
156
Virtu Financial
New York
-$59K -876 Closed
JF
157
Jump Financial
Illinois
-$54K -809 Closed
QT
158
Quantbot Technologies
New York
-$54K -804 Closed
PP
159
PDT Partners
New York
-$46K -682 Closed
Federated Hermes
160
Federated Hermes
Pennsylvania
-$22K -329 Closed
PI
161
PEAK6 Investments
Illinois
-$8.15K -303 Closed
CAPTRUST Financial Advisors
162
CAPTRUST Financial Advisors
North Carolina
-$5K -67 Closed
Rockefeller Capital Management
163
Rockefeller Capital Management
New York
-$4K -60 Closed
Man Group
164
Man Group
United Kingdom
-$85K